Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Sanofi-Aventis S.A. (SNY)

49.33   0.4 (0.82%) 10-24 13:27
Open: 49.48 Pre. Close: 48.93
High: 49.5 Low: 48.92
Volume: 728,178 Market Cap: 123,108M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 49.615 - 49.944 49.944 - 50.241
Low: 48.095 - 48.52 48.52 - 48.905
Close: 48.679 - 49.343 49.343 - 49.943

Technical analysis

as of: 2020-10-23 4:49:05 PM
Overall:       
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 58.90     One year: 60.35
Support: Support1: 48.43    Support2: 40.29
Resistance: Resistance1: 50.43    Resistance2: 51.67
Pivot: 50.18
Moving Average: MA(5): 49.49     MA(20): 50.24
MA(100): 51.20     MA(250): 49.06
MACD: MACD(12,26): -0.39     Signal(9): -0.25
Stochastic oscillator: %K(14,3): 10.60     %D(3): 16.41
RSI: RSI(14): 42.21
52-week: High: 55.00  Low: 37.62  Change(%): 6.3
Average Vol(K): 3-Month: 100961  10-Days: 102866

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
SNY has closed above bottom band by 21.8%. Bollinger Bands are 6.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 02 Sep 2020
3 Pharma Stocks That Are COVID-19 Resistant - Benzinga

Wed, 15 Jul 2020
Sanofi: Buy And Permanently Hold A Value Stock With A Limited Short-Term Downside - Seeking Alpha

Tue, 23 Jun 2020
Sanofi, a straggler in the Covid-19 vaccine race, accelerates its plans - STAT

Tue, 26 May 2020
Cannabis Company Aphria To Switch Listing From NYSE To Nasdaq - Benzinga

Thu, 09 Apr 2020
Is Sanofi (SNY) a Great Value Stock Right Now? - Yahoo Finance

Tue, 07 Apr 2020
Trump’s personal stake in the malaria-drug maker Sanofi could be as small as $99 - MarketWatch

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Neutral Discounted cash flow: Neutral
Return on Assets: Neutral Price to Earnings: Neutral
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Drug Manufacturers General
Shares Out. (M) 2,510
Shares Float (M) 2,230
% Held by Insiders
% Held by Institutions 8.09
Shares Short (K) 3,400
Shares Short P. Month (K) 3,520

Stock Financials

EPS 1.940
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 26.250
Profit Margin 29.28
Operating Margin
Return on Assets (ttm) 4.0
Return on Equity (ttm) 18.6
Qtrly Rev. Growth -6.0
Gross Profit (p.s.) 10.223
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio 25.43
PEG Ratio 3.88
Price to Book value 1.88
Price to Sales
Price to Cash Flow

Stock Dividends

Dividend 3.530
Forward Dividend 1.700
Dividend Yield 0.07
Dividend Pay Date 2020-05-25
Ex-Dividend Date 2020-04-29
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.